Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein response.
Ontology highlight
ABSTRACT: Despite advances toward understanding the prevention and treatment of many cancers, patients who suffer from oral squamous cell carcinoma (OSCC) confront a survival rate that has remained unimproved for more than 2 decades, indicating our ability to treat them pharmacologically has reached a plateau. In an ongoing effort to improve the clinical outlook for this disease, we previously reported that an essential component of the mechanism by which the proteasome inhibitor bortezomib (PS-341, Velcade) induced apoptosis in OSCC required the activation of a terminal unfolded protein response (UPR). Predicated on these studies, the authors hypothesized that high-throughput screening (HTS) of large diverse chemical libraries might identify more potent or selective small-molecule activators of the
SUBMITTER: Fribley AM
PROVIDER: S-EPMC3374590 | biostudies-literature | 2011 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA